HomeNKTR • NASDAQ
add
Nektar Therapeutics
Previous close
$72.21
Day range
$72.59 - $75.80
Year range
$6.50 - $77.00
Market cap
2.15B USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 21.81M | -25.25% |
Operating expense | 40.90M | -10.86% |
Net income | -36.08M | -596.89% |
Net profit margin | -165.45 | -764.72% |
Earnings per share | -1.29 | 42.68% |
EBITDA | -18.90M | 22.38% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 245.75M | -3.71% |
Total assets | 280.41M | -7.72% |
Total liabilities | 190.57M | -21.61% |
Total equity | 89.83M | — |
Shares outstanding | 28.69M | — |
Price to book | 16.37 | — |
Return on assets | -16.41% | — |
Return on capital | -19.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -36.08M | -596.89% |
Cash from operations | -64.96M | -40.64% |
Cash from investing | 372.00K | -99.38% |
Cash from financing | 38.67M | 46,491.57% |
Net change in cash | -25.92M | -283.24% |
Free cash flow | -36.85M | -358.10% |
About
Founded
1990
Headquarters
Website
Employees
63
